Merus N.V. revenue for the last year amounted to 39.82 M EUR, the most of which — 39.82 M EUR — came from its highest performing source at the moment, Innovative Therapeutics, the year earlier bringing 38.86 M EUR. The greatest contribution to the revenue figure was made by Netherlands — last year it brought Merus N.V. 39.82 M EUR, and the year before that — 38.86 M EUR.